Blinding
At all stages of the study, methadone dose adjustments (ie, manipulations of the primary outcome) were overseen by addiction medicine physicians blinded to treatment allocation. Physicians, nurse practitioners, and counselors were also blinded, as were data analysts. Other study team members were blinded for all of day 1.